http://www.biospectrumasia.com/content/280711SGP16734.asp
Health Sciences Authority (HSA) in Singapore has approved a new treatment, olmesartan medoxomil/amlodipine besylate, for high blood pressure.
Olmesartan medoxomil is an angiotensin II receptor blocker Amlodipine besylate relaxes the blood vessels so that they dilate and the blood pressure within them drops.
Health Sciences Authority (HSA) in Singapore has approved a new treatment, olmesartan medoxomil/amlodipine besylate, for high blood pressure.
Olmesartan medoxomil is an angiotensin II receptor blocker Amlodipine besylate relaxes the blood vessels so that they dilate and the blood pressure within them drops.